Shincheonji announced on 27 August members will continue plasma donations to help accelerate the development of a vaccine for Covid-19
NEW YORK, NEW YORK, USA, August 28, 2020 /EINPresswire.com/ — Shincheonji Church of Jesus, the Temple of the Tabernacle of Testimony (SCJ), announced that it will be donating plasma once again.
Shincheonji announced on 27 August members will continue plasma donations to help accelerate the development of a vaccine for Covid-19.
Nearly 1,100 Shincheonji members who have antibodies for the Covid-19 infection will have donated plasma by the end of the donation period. It was previously reported 1,100 have already made the donations, however the number reflects the projected donations by 4 September. The plasma donation is being held at the Daegu Athletics Promotion Center 27 August to 4 September. On the first day 160 people participated in the drive.
Shincheonji’s Daegu branch participated in an initial plasma donation on 13-17 July. To date, Shincheonji has reported that 628 members donated plasma. When the plasma donation to the second group is completed, a total of 1,700 believers will have participated in the plasma donation.
“We will continue to work closely with the Korea Centers for Disease Control and Prevention (KCDC) to make every effort to overcome Corona 19,” said a spokesperson from the SCJ Daegu branch.
Bloggers originally against SCJ have posted comments which now show signs of support. Some comments made include, “I’m sorry for the curses at first,” “Let’s end Covid-19 as soon as possible,” “Let’s quickly develop a cure and end Corona together.”
The Korea Centers for Disease Control and Prevention officially requested Shincheonji to cooperate with the donation of plasma to develop a plasma treatment for Covid-19.
According to the Centers for Disease Control and Prevention on the 26th, KCDC recently sent such a memorandum to the Shincheonji Church of Jesus Testimony.
In an official letter the KCDC stated, “As the outbreak of Covid-19 at home and abroad is on the rise again, more rapid development of therapeutic agents is required through group plasma donations, so we ask for active cooperation as we are seeking to recruit plasma through your institution.”
email us here